2014年1月6日 Thermo Fisher Scientific Inc(NYSE:TMO)今天发布消息称，公司将以10.6亿美元向General Electric Co出售旗下三个部门，执行欧洲反垄断机构的一个要求以批准购买Life Technologies Corp。十一月份时欧盟已批准Thermo Fisher的136亿美元Life Technologies收购协议。这三个部门分别为细胞培养、基因调控和磁珠部门。此次协议预期将于今年年初完成，但仍需获得美国的批准。
      
      通用电气医疗副总裁、医疗生命科学事业部总裁兼CEO Kieran Murphy表示：“这项交易除了能够给予我们新的手段进行药物探索和生物医疗方面的研究外，还是我们带领客户朝着生物制药方面所迈出的重大一步。”

预计这项交易将有助于通用电气医疗部门扩大并加速其在细胞生物研究、细胞治疗等方面的技术进展。

Thermo Fisher Scientific Reaches Agreement to Sell its Cell Culture, Gene Modulation and Magnetic Beads Businesses to GE Healthcare

Monday, January 6, 2014 
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company (NYSE: GE), for approximately $1.06 billion. The businesses will become part of GE Healthcare’s Life Sciences division.

The combined revenue of the three businesses, which are primarily part of Thermo Fisher’s Analytical Technologies Segment, is expected to be approximately $250 million in 2013. Thermo Fisher committed to sell these businesses to expedite approval of its pending acquisition of Life Technologies Corporation (NASDAQ: LIFE) by the European Commission.

The acquisition remains subject to additional regulatory approvals, including the U.S. Federal Trade Commission (FTC). Based on its discussions with the FTC, Thermo Fisher does not believe any additional divestures will be required in order to receive U.S. approval. The company is working with the remaining jurisdictions to obtain the approvals required to complete the acquisition as soon as possible, and continues to expect to close in early 2014.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenue of $13 billion, we have 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visitwww.thermofisher.com.